Alteration of platelet function in dogs mediated by interleukin-6.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Blood

• Publication date

  1994-01-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V83.2.398.BLOODJOURNAL832398PMID 7506949
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of three human recombinant hematopoietic growth factors (granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, and interleukin-3) on phagocyte oxidative activity.

  1993cited by this paper
• The effects of leukaemia inhibitory factor on platelet function

  1993cited by this paper
• Characteristics of a novel rat anti-mouse platelet monoclonal antibody: application to studies of megakaryocytes.

  1992cited by this paper
• Thrombocytopoiesis in normal and sublethally irradiated dogs: response to human interleukin-6.

  1992cited by this paper
• In vivo effects of interleukin-6 on thrombopoiesis in healthy and irradiated primates.

  1992cited by this paper
• Essential groups in synthetic agonist peptides for activation of the platelet thrombin receptor.

  1992cited by this paper
• Platelet‐activating factor receptor and signal transduction mechanisms 1

  1992cited by this paper
• In vivo effects of interleukin-6 on thrombopoiesis in healthy and irradiated primates [see comments]

  1992cited by this paper
• Thrombocytopoiesis in normal and sublethally irradiated dogs: response to human interleukin-6

  1992cited by this paper
• Stimulation of megakaryocytopoiesis in mice by human recombinant interleukin-6.

  1991cited by this paper
• Effects of human interleukin-6 on megakaryocyte development and thrombocytopoiesis in primates.

  1991cited by this paper
• Effect of fibrinogen concentration on the velocity of platelet aggregation.

  1991cited by this paper
• Comparative effects of thrombopoietin and interleukin-6 on murine megakaryocytopoiesis and platelet production.

  1991cited by this paper
• Canine megakaryocytopoiesis: analysis utilizing a monoclonal antibody to a 140-kd dog platelet protein.

  1991cited by this paper
• Recombinant human interleukin 6 is a potent inducer of the acute phase response and elevates the blood platelets in nonhuman primates.

  1991cited by this paper
• Interleukin-6 and its receptor are expressed by human megakaryocytes: in vitro effects on proliferation and endoreplication.

  1991cited by this paper
• Stimulation of thrombopoiesis in mice by human recombinant interleukin 6.

  1990cited by this paper
• In vivo effects of recombinant human interleukin-6 in primates: stimulated production of platelets.

  1990cited by this paper
• Thrombin-induced increase in surface expression of epitopes on platelet membrane glycoprotein IIb/IIIa complex and GMP-140 is a function of platelet age.

  1989cited by this paper
• Interleukin-6 is a potent thrombopoietic factor in vivo in mice.

  1989cited by this paper
• Effect of interleukin 6 on in vitro human megakaryocytopoiesis: its interaction with other cytokines.

  1989cited by this paper
• Respiratory burst in adherent human neutrophils: triggering by colony-stimulating factors CSF-GM and CSF-G.

  1989cited by this paper
• Heterogeneity of fibrinogen receptor expression on platelets activated in normal plasma with ADP: analysis by flow cytometry

  1989cited by this paper
• Respiratory burst in adherent human neutrophils: triggering by colony- stimulating factors CSF-GM and CSF-G

  1989cited by this paper
• The pathophysiology and clinical relevance of platelet heterogeneity.

  1988cited by this paper
• Heterogeneity of platelet secretion in response to thrombin demonstrated by fluorescence flow cytometry.

  1987cited by this paper
• Molecular cloning and expression of hybridoma growth factor in Escherichia coli.

  1987cited by this paper
• Platelet size and age determine platelet function independently.

  1984cited by this paper
• Platelet size and age determine platelet function independently

  1984cited by this paper
• Technical considerations for platelet aggregation and related problems

  1983cited by this paper
• Technical considerations for platelet aggregation and related problems.

  1983cited by this paper
• Functional fractionation of platelets.

  1981cited by this paper
• Functional fractionation of platelets.

  1981cited by this paper
• Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences.

  1980cited by this paper
• Heterogeneity of platelet function. Correlation with platelet volume.

  1978cited by this paper
• Platelet Age: its Relationship to Platelet Size, Function and Metabolism

  1972cited by this paper
• Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets.

  1969cited by this paper
• The effect of platelet age on platelet adherence to collagen.

  1968cited by this paper

• Interleukin-6: A Novel Risk Factor and Therapeutic Target in Coronary Artery Disease

  2025cites this paper
• IL-6 as a Mediator of Platelet Hyper-Responsiveness

  2025cites this paper
• Diindolylmethane Ameliorates Ischemic Stroke-Induced Brain Injury by Peripheral and Central Mechanisms.

  2022cites this paper
• The Effect of IL-6-Primed Platelets on ADAMTS13-Mediated Clearance of Platelet-Bearing ULVWF and Its Mechanism

  2021cites this paper
• The Role of T-cell Costimulation in the Pathogenesis of Kawasaki Disease

  2019cites this paper
• Endothelial alterations in a canine model of immune thrombocytopenia

  2019cites this paper
• The Role of Platelets in Antimicrobial Host Defense

  2019cites this paper
• Atorvastatin induces associated reductions in platelet P-selectin, oxidized LDL and IL-6 in patients with coronary artery diseases

  2017cites this paper
• Interleukin-6 mediates enhanced thrombus development in cerebral arterioles following a brief period of focal brain ischemia.

  2015cites this paper
• Do we need antiplatelet therapy in thrombocytosis? Pro

  2015cites this paper
• Interleukin-6 and Asymmetric Dimethylarginine Are Associated with Platelet Activation after Percutaneous Angioplasty with Stent Implantation

  2015cites this paper
• Interleukin-6 mediates the platelet abnormalities and thrombogenesis associated with experimental colitis.

  2013cites this paper
• Interleukin 6 and lipopolysaccharide binding protein - markers of inflammation in acute appendicitis.

  2013influential citation
• Antimicrobial Host Defense

  2013cites this paper
• treated dogs Relative reactivity of platelets from thrombopoietin- and interleukin-6-

  2013cites this paper
• Effect of recombinant canine interleukin-6 and interleukin-8 on tissue factor procoagulant activity in canine peripheral blood mononuclear cells and purified canine monocytes.

  2012cites this paper
• Análise do perfil hemostático e do risco tromboembólico em cães submetidos ao tratamento com prednisona

  2012cites this paper
• Analytic Review: Interleukin-6 in Surgery, Trauma, and Critical Care: Part I: Basic Science

  2011influential citation
• Abstract O.27: The Role Of CD40L And CD40 In The Pathogenesis Of Kawasaki Disease

  2011cites this paper
• A dietary approach to increase in-stent stenosis and face validity of a rat model for arterial angioplasty and stenting.

  2011cites this paper
• Correlation and association of plasma interleukin-6 and plasma platelet-derived microparticles, markers of activated platelets, in healthy individuals.

  2010cites this paper
• Inhibitory Effects of Megakaryocytic Cells in Prostate Cancer Skeletal Metastasis

  2010cites this paper
• Platelets in defense against bacterial pathogens

  2009cites this paper
• Platelet dysfunction in central obesity.

  2009cites this paper
• Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases

  2008influential citation
• Roles of IL-6-gp130 Signaling in Vascular Inflammation

  2008cites this paper
• CHAPTER 40 – Antimicrobial Host Defense

  2007cites this paper
• Cancer Treatment and Research

  2005cites this paper
• Endothelium and inflammation.

  2005cites this paper
• Heparin-induced thrombocytopenia.

  2004cites this paper
• Platelet-derived microparticles in patients with arteriosclerosis obliterans: enhancement of high shear-induced microparticle generation by cytokines.

  2000cites this paper
• Inflammatory Aspects of Acute Coronary Syndromes

  2000cites this paper
• Platelets Expressing P-Selectin and Platelet-Derived Microparticles in Stored Platelet Concentrates Bind to PSGL-1 on Filtrated Leukocytes

  2000cites this paper
• Staphylococcus aureus, platelets, and the heart

  2000cites this paper
• Heparin-induced thrombocytopenia

  2000cites this paper
• A role for changes in platelet production in the cause of acute coronary syndromes.

  1999cites this paper
• [The role of inflammation in the pathogenesis and prognosis of unstable angina].

  1999cites this paper
• Role of inflammation in the pathogenesis of unstable coronary artery diseases.

  1999cites this paper
• Bleeding induced interleukin-6 decreases blood loss via activation of coagulation.

  1999cites this paper
• Selectins and IL-6 during the Clinical Course of Idiopathic Thrombocytopenic Purpura

  1999cites this paper
• Platelets from thrombocytopenic ponies acutely infected with equine infectious anemia virus are activated in vivo and hypofunctional.

  1999cites this paper
• Biological response modifiers: interferons, interleukins, recombinant products, liposomal products.

  1998cites this paper
• Chronic Myeloid Leukemia: Current Guidelines for Diagnosis and Management.

  1998cites this paper
• Thrombopoietin, interleukin-6, and P-selectin at diagnosis and during post-steroid recovery period of patients with autoimmune thrombocytopenic purpura

  1998cites this paper
• Megakaryocytes and platelets in vascular disease.

  1997cites this paper
• Effect of Cytokines on the Development of Megakaryocytes and Platelets

  1997cites this paper
• 6 Megakaryocytes and platelets in vascular disease

  1997cites this paper
• Role of inflammation in the pathogenesis of unstable coronary artery disease.

  1997cites this paper
• Cytokines, platelet production and hemostasis.

  1997cites this paper
• The role of platelets in antimicrobial host defense.

  1997cites this paper
• Recombinant cytokines and hematopoietic growth factors in allogeneic and autologous bone marrow transplantation.

  1997cites this paper
• Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

  1996cites this paper
• Inhibition of the acute‐phase response in vivo by anti‐gp130 monoclonal antibodies

  1996cites this paper
• Chronic myelogenous leukemia: a review.

  1996cites this paper
• Cytokine–Induced Alteration of Platelet and Hemostatic Function

  1996cites this paper
• Results of interferon-alpha therapy in patients with chronic myelogenous leukemia 60 years of age and older

  1996cites this paper
• Immunocytochemistry and flow cytometry evaluation of human megakaryocytes in fresh samples and cultures of CD34+ cells.

  1996cites this paper
• Relative reactivity of platelets from thrombopoietin- and interleukin-6-treated dogs.

  1996cites this paper
• Interleukin-6 and megakaryocytopoiesis: an update

  1996cites this paper
• Alterations in platelet function in patients receiving interleukin-6 as cytokine therapy.

  1996cites this paper
• Morphologic and ultrastructural evidence for interleukin‐6 induced platelet activation

  1995cites this paper
• Recombinant human interleukin-6: safety issues of a pleiotropic growth factor.

  1995cites this paper
• rmIL-6 stimulates the transcriptional activity of the rat PF4 gene.

  1995cites this paper
• Thrombocytopenia in dogs induced by granulocyte-macrophage colony-stimulating factor: increased destruction of circulating platelets.

  1995cites this paper
• Cytokines and Thrombosis

  1995cites this paper
• Megakaryocytopoiesis: cellular aspects and regulation.

  1995cites this paper
• A phase I trial of recombinant human interleukin-6 in patients with myelodysplastic syndromes and thrombocytopenia.

  1995cites this paper
• Platelet transfusion and alternatives to transfusion in patients with malignancy

  1995cites this paper
• Phase I multicenter trial of interleukin 6 therapy after autologous bone marrow transplantation in advanced breast cancer.

  1995cites this paper
• A phase I/II trial of recombinant human interleukin‐6 in patients with aplastic anaemia

  1995cites this paper
• Effects of interleukin 6 on megakaryocytes and on canine platelet function

  1994cites this paper
• Cytokine production by primary bone marrow megakaryocytes.

  1994cites this paper